Featured Research

from universities, journals, and other organizations

Last-resort therapy saving lives during flu epidemic

Date:
January 22, 2014
Source:
University of Alabama at Birmingham
Summary:
Physicians are employing a technology known as ECMO as a last-resort therapy for extremely severe cases of influenza. ECMO is a sort of portable heart/lung bypass machine.

In extreme cases of flu, severe inflammation can cause the lungs to fail. ECMO essentially takes on the function of the lungs for a period of time by routing a patient’s blood into the machine where carbon dioxide is removed and oxygen is added. The blood is then pumped back into the body.
Credit: University of Alabama at Birmingham

Physicians at the University of Alabama at Birmingham are employing a technology known as ECMO as a last-resort therapy for extremely severe cases of influenza. ECMO, short for extracorporeal membrane oxygenation, is a sort of portable heart/lung bypass machine.

The machine was first developed for use in heart bypass surgery, and has also found utilization as a bridge to heart or lung transplantation and the treatment of other severe lung diseases.

In extreme cases of flu, severe inflammation can cause the lungs to fail. ECMO essentially takes on the function of the lungs for a period of time by routing a patient's blood into the machine where carbon dioxide is removed and oxygen is added. The blood is then pumped back into the body. Patients can remain on ECMO until the inflammation is reduced and the lungs are capable of functioning normally on their own.

UAB has used ECMO on more than a dozen adult patients with severe flu since the start of the flu season, and more than 50 adult patients with cardiopulmonary failure were treated with ECMO at UAB in 2013.

"These are very sick patients for whom traditional therapy such as a ventilator is simply not sufficient," said Enrique Diaz, M.D., associate professor in the Division of Pulmonary, Allergy and Critical Care Medicine and head of the UAB ECMO program. "By taking on the functions of the lungs and/or the heart, ECMO supports the body's normal function and gives these patients time to recover."

Use of ECMO is a complicated process. Patients can remain on ECMO in the intensive care unit for several weeks if necessary. Many require rehabilitation after coming off the machine.

ECMO requires a dedicated team of medical professionals, including intensive care specialists, surgeons, perfusionists, nurses trained in ECMO use, and respiratory and physical therapists.

"ECMO is a very specialized treatment, and typically only major academic medical centers will have the equipment, expertise and experience to employ ECMO for flu cases," said Diaz.

UAB has seven ECMO machines which have stayed busy since the start of flu season. Patients from hard-hit areas, including the Florida and Alabama Gulf Coast region, have been referred to the UAB ECMO program, along with patients from across Alabama.

"ECMO is not a cure, but it is a way to support some of these very critically ill patients who are failing conventional medical therapy, failing mechanical ventilation," said Diaz. "Many patients are being saved through the use of this technology."


Story Source:

The above story is based on materials provided by University of Alabama at Birmingham. Note: Materials may be edited for content and length.


Cite This Page:

University of Alabama at Birmingham. "Last-resort therapy saving lives during flu epidemic." ScienceDaily. ScienceDaily, 22 January 2014. <www.sciencedaily.com/releases/2014/01/140122133639.htm>.
University of Alabama at Birmingham. (2014, January 22). Last-resort therapy saving lives during flu epidemic. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/01/140122133639.htm
University of Alabama at Birmingham. "Last-resort therapy saving lives during flu epidemic." ScienceDaily. www.sciencedaily.com/releases/2014/01/140122133639.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins